Literature DB >> 17227118

Clear cell sarcoma of tendons and aponeuroses: a review.

Daniel C Dim1, Linda D Cooley, Roberto N Miranda.   

Abstract

Clear cell sarcoma of tendons and aponeuroses, also referred to as malignant melanoma of soft parts, is a rare malignancy derived from neural crest cells. It usually presents in the distal lower extremities of young adults, frequently attached to tendons or aponeuroses. It behaves like a high-grade soft tissue sarcoma and is associated with poor overall survival. Magnetic resonance imaging studies of the lesion reveal T1 hypointensity, T2 hyperintensity, and gadolinium uptake. Grossly, the tumor is usually circumscribed with a histologic pattern of uniform polygonal to fusiform cells with clear to pale eosinophilic cytoplasm divided into variably sized clusters by fibrous septa. Immunohistochemical studies in most cases show that the neoplastic cells are positive with HMB-45 and react with antibody against S100 protein. Most cases show a reciprocal cytogenetic translocation t(12;22)(q13;q12) that creates a unique chimeric fusion EWSR1/ATF1 gene transcript. Metastasis occurs mainly to regional lymph nodes and lungs. Poor prognostic indicators include a tumor size equal to or more than 5 cm, presence of metastasis, and necrosis. The mainstay of treatment is wide excision of the tumor. The use of sentinel lymph node biopsy may become an important procedure in detecting occult regional metastasis and guiding the extent of surgery. The beneficial effects of adjuvant chemotherapy and radiotherapy have not been fully evaluated. This article provides a short overview of the current knowledge of clear cell sarcoma of tendons and aponeuroses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17227118     DOI: 10.5858/2007-131-152-CCSOTA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  27 in total

1.  Clear cell sarcoma.

Authors:  Pinar Ozuguz; Mukadder Kocak; Pinar Atasoy; Ibrahim Vargel; Tarik Cavusoglu
Journal:  Indian Dermatol Online J       Date:  2014-10

2.  Primary clear cell sarcoma of the sacrum: a case report.

Authors:  Weibin Zhang; Yuhui Shen; Rong Wan; YanBo Zhu
Journal:  Skeletal Radiol       Date:  2010-12-23       Impact factor: 2.199

Review 3.  Clear cell sarcoma-A review.

Authors:  Rami Mossad Ibrahim; Signe Steenstrup Jensen; Jacob Juel
Journal:  J Orthop       Date:  2018-09-06

Review 4.  Clear cell sarcoma of the esophagus: report of a case.

Authors:  Daisuke Ishii; Mitsuhiro Inagaki; Tatsuya Shonaka; Hiromitsu Akabane; Naoyuki Yanagida; Hiroki Shomura; Tatsuya Orimo; Takeshi Aiyama; Keisuke Sato; Shiro Nakano
Journal:  Clin J Gastroenterol       Date:  2014-03-30

5.  Clear cell sarcoma of the penis: a case report.

Authors:  Timothy Ito; Jonathan Melamed; Mary Ann Perle; Joseph Alukal
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

6.  Clear cell sarcoma of soft tissue in right parapharyngeal region: report of a rare case.

Authors:  Chuifeng Fan; Juanhan Yu; Lianhe Yang; Xuyong Lin; Enhua Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  The RNA Pol II sub-complex hsRpb4/7 is required for viability of multiple human cell lines.

Authors:  Yang Zhao; Kim K C Li; King Pan Ng; Chi Ho Ng; Kevin A W Lee
Journal:  Protein Cell       Date:  2012-10-17       Impact factor: 14.870

8.  Clear cell sarcoma of the upper thoracic back muscle.

Authors:  Dae-Hyun Kim; Ki-Hwan Choi; Young-Dae Cho
Journal:  J Korean Neurosurg Soc       Date:  2009-02-28

9.  Clear cell sarcoma expressing a novel chimerical transcript EWSR1 exon 7/ATF1 exon 6.

Authors:  Egle Gineikiene; Dmitrij Seinin; Birute Brasiuniene; Andrius Brazaitis; Laimonas Griskevicius; Arturas Jakubauskas
Journal:  Virchows Arch       Date:  2012-08-11       Impact factor: 4.064

Review 10.  Clinicopathological features, diagnosis and treatment of clear cell sarcoma/melanoma of soft parts.

Authors:  Af Mavrogenis; G Bianchi; Na Stavropoulos; Pj Papagelopoulos; P Ruggieri
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.